-
公开(公告)号:US08877759B2
公开(公告)日:2014-11-04
申请号:US13440981
申请日:2012-09-04
申请人: Jean-Damien Charrier , David Kay , Somhairle MacCormick , Pierre-Henri Storck , Joanne Pinder , Michael Edward O'Donnell , Ronald Marcellus Alphonsus Knegtel , Stephen Clinton Young , Philip Michael Reaper , Steven John Durrant , Heather Clare Twin , Christopher John Davis
发明人: Jean-Damien Charrier , David Kay , Somhairle MacCormick , Pierre-Henri Storck , Joanne Pinder , Michael Edward O'Donnell , Ronald Marcellus Alphonsus Knegtel , Stephen Clinton Young , Philip Michael Reaper , Steven John Durrant , Heather Clare Twin , Christopher John Davis
IPC分类号: A61K31/4965 , C07D403/00 , A61K31/501 , A61K45/06 , A61K31/55 , A61K31/5377 , A61K31/7068 , C07D413/14 , C07D495/04 , A61K31/7048 , A61K33/24 , A61K31/497 , C07D453/00
CPC分类号: C07D413/14 , A61K31/497 , A61K31/501 , A61K31/5377 , A61K31/55 , A61K31/555 , A61K31/7048 , A61K31/7068 , A61K33/24 , A61K45/06 , C07D453/00 , C07D453/02 , C07D495/04 , A61K2300/00
摘要: The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors.The compounds of this invention have formula I: wherein the variables are as defined herein.
摘要翻译: 本发明涉及可用作ATR蛋白激酶抑制剂的化合物。 本发明还涉及包含本发明化合物的药学上可接受的组合物; 使用本发明化合物治疗各种疾病,病症和病症的方法; 制备本发明化合物的方法; 用于制备本发明化合物的中间体; 以及在体外应用中使用化合物的方法,如生物和病理现象中激酶的研究; 由这种激酶介导的细胞内信号转导途径的研究; 和新型激酶抑制剂的比较评估。 本发明的化合物具有式I:其中变量如本文所定义。
-
公开(公告)号:US20130095193A1
公开(公告)日:2013-04-18
申请号:US13440981
申请日:2012-09-04
申请人: Jean-Damien Charrier , Somhairle MacCormick , Pierre-Henri Storck , Joanne Pinder , Michael Edward O'Donnell , Ronald Marcellus Alphonsus Knegtel , Stephen Clinton Young , Philip Michael Reaper , Steven John Durrant , Heather Clare Twin , Christopher John Davis
发明人: Jean-Damien Charrier , David Kay , Somhairle MacCormick , Pierre-Henri Storck , Joanne Pinder , Michael Edward O'Donnell , Ronald Marcellus Alphonsus Knegtel , Stephen Clinton Young , Philip Michael Reaper , Steven John Durrant , Heather Clare Twin , Christopher John Davis
IPC分类号: C07D413/14 , A61K31/5377 , C07D453/00 , C07D495/04 , A61K31/7068 , A61K45/06 , A61K31/501 , A61K31/55 , A61K31/7048 , A61K31/497 , A61K33/24
CPC分类号: C07D413/14 , A61K31/497 , A61K31/501 , A61K31/5377 , A61K31/55 , A61K31/555 , A61K31/7048 , A61K31/7068 , A61K33/24 , A61K45/06 , C07D453/00 , C07D453/02 , C07D495/04 , A61K2300/00
摘要: The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors.The compounds of this invention have formula I: wherein the variables are as defined herein.
摘要翻译: 本发明涉及可用作ATR蛋白激酶抑制剂的化合物。 本发明还涉及包含本发明化合物的药学上可接受的组合物; 使用本发明化合物治疗各种疾病,病症和病症的方法; 制备本发明化合物的方法; 用于制备本发明化合物的中间体; 以及在体外应用中使用化合物的方法,如生物和病理现象中激酶的研究; 由这种激酶介导的细胞内信号转导途径的研究; 和新型激酶抑制剂的比较评估。 本发明的化合物具有式I:其中变量如本文所定义。
-
公开(公告)号:US20130089624A1
公开(公告)日:2013-04-11
申请号:US13631730
申请日:2012-09-28
IPC分类号: C07D413/14 , A61K33/24 , C07D267/10 , C07D413/10 , C07D413/04 , A61K31/5377 , C07D265/30
CPC分类号: A61K31/5377 , A61K33/24 , C07D265/30 , C07D267/10 , C07D401/04 , C07D413/04 , C07D413/10 , C07D413/14
摘要: The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors.The compounds of this invention have formula I: wherein the variables are as defined herein.Additionally, the present invention also relates to novel processes for the production of various morpoholine based intermediates.
摘要翻译: 本发明涉及可用作ATR蛋白激酶抑制剂的化合物。 本发明还涉及包含本发明化合物的药学上可接受的组合物; 使用本发明化合物治疗各种疾病,病症和病症的方法; 制备本发明化合物的方法; 用于制备本发明化合物的中间体; 以及在体外应用中使用化合物的方法,如生物和病理现象中激酶的研究; 由这种激酶介导的细胞内信号转导途径的研究; 和新型激酶抑制剂的比较评估。 本发明的化合物具有式I:其中变量如本文所定义。 此外,本发明还涉及用于生产各种基于morpoholine的中间体的新方法。
-
公开(公告)号:US08741931B2
公开(公告)日:2014-06-03
申请号:US13442244
申请日:2012-04-09
申请人: Juan-Miguel Jimenez , Guy William Bemis , Francois Maltais , Tiansheng Wang , Ronald Marcellus Alphonsus Knegtel , Christopher John Davis , Damien Fraysse , Dean Boyall , Luca Settimo , Stephen Young , Michael Paul Mortimore
发明人: Juan-Miguel Jimenez , Guy William Bemis , Francois Maltais , Tiansheng Wang , Ronald Marcellus Alphonsus Knegtel , Christopher John Davis , Damien Fraysse , Dean Boyall , Luca Settimo , Stephen Young , Michael Paul Mortimore
IPC分类号: A61K31/444
CPC分类号: C07D213/73 , C07D401/04 , C07D401/12 , C07D401/14 , C07D409/06 , C07D409/14 , C07D417/06 , C07D417/14 , C07D487/04 , C07D487/08
摘要: The present invention relates to compounds having formula: which are useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
摘要翻译: 本发明涉及具有下式的化合物:其可用作蛋白激酶的抑制剂。 本发明还提供包含所述化合物的药学上可接受的组合物和使用该组合物治疗各种疾病,病症或病症的方法。 本发明还提供了制备本发明化合物的方法。
-
公开(公告)号:US08377926B2
公开(公告)日:2013-02-19
申请号:US13020947
申请日:2011-02-04
申请人: Francois Maltais , Guy W. Bemis , Tiansheng Wang , Juan-Miguel Jimenez , Luca Settimo , Stephen Young , Dean Boyall , Damien Fraysse , Christopher John Davis
发明人: Francois Maltais , Guy W. Bemis , Tiansheng Wang , Juan-Miguel Jimenez , Luca Settimo , Stephen Young , Dean Boyall , Damien Fraysse , Christopher John Davis
IPC分类号: A61K31/44 , C07D213/62
CPC分类号: C07D417/14 , C07D213/73 , C07D213/74 , C07D401/04 , C07D401/10 , C07D401/14 , C07D407/04 , C07D407/12
摘要: The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
摘要翻译: 本发明涉及可用作蛋白激酶抑制剂的化合物。 本发明还提供包含所述化合物的药学上可接受的组合物和使用该组合物治疗各种疾病,病症或病症的方法。 本发明还提供了制备本发明化合物的方法。
-
公开(公告)号:US20110060013A1
公开(公告)日:2011-03-10
申请号:US12601026
申请日:2009-11-20
申请人: Michael Paul Mortimore , Christopher John Davis , Julian M.C. Golec , John Studley , Daniel David Robinson
发明人: Michael Paul Mortimore , Christopher John Davis , Julian M.C. Golec , John Studley , Daniel David Robinson
IPC分类号: A61K31/4439 , C07D401/14 , C07D417/14 , A61P35/00
CPC分类号: C07D401/14 , C07D417/14
摘要: The present invention relates to compounds useful as inhibitors of Aurora protein kinases. The invention also provides pharmaceutically acceptable compositions comprising those compounds and methods of using the compounds and compositions in the treatment of various disease, conditions, and disorders. The invention also provides processes for preparing compounds of the invention.
摘要翻译: 本发明涉及可用作Aurora蛋白激酶抑制剂的化合物。 本发明还提供包含这些化合物的药学上可接受的组合物和使用该化合物和组合物治疗各种疾病,病症和障碍的方法。 本发明还提供了制备本发明化合物的方法。
-
公开(公告)号:US08809335B2
公开(公告)日:2014-08-19
申请号:US13560131
申请日:2012-07-27
申请人: Juan-Miguel Jimenez , Luca Settimo , Damien Fraysse , Guy Brenchley , Christopher John Davis , Andrew W. Miller
发明人: Juan-Miguel Jimenez , Luca Settimo , Damien Fraysse , Guy Brenchley , Christopher John Davis , Andrew W. Miller
IPC分类号: A61K31/497
CPC分类号: C07D487/04
摘要: The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
摘要翻译: 本发明涉及可用作蛋白激酶抑制剂的化合物。 本发明还提供包含所述化合物的药学上可接受的组合物和使用该组合物治疗各种疾病,病症或病症的方法。 本发明还提供了制备本发明化合物的方法。
-
公开(公告)号:US20130053388A1
公开(公告)日:2013-02-28
申请号:US13560122
申请日:2012-07-27
申请人: Juan-Miguel Jimenez , Luca Settimo , Damien Fraysse , Guy Brenchley , Christopher John Davis , Andrew W. Miller
发明人: Juan-Miguel Jimenez , Luca Settimo , Damien Fraysse , Guy Brenchley , Christopher John Davis , Andrew W. Miller
IPC分类号: A61K31/4985 , A61P37/06 , A61P29/00 , A61P35/00 , A61P11/06 , A61P19/04 , A61P19/02 , A61P25/00 , A61P3/10 , A61P1/00 , A61P35/02 , C07D487/04 , A61P17/06
CPC分类号: C07D487/04
摘要: The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
摘要翻译: 本发明涉及可用作蛋白激酶抑制剂的化合物。 本发明还提供包含所述化合物的药学上可接受的组合物和使用该组合物治疗各种疾病,病症或病症的方法。 本发明还提供了制备本发明化合物的方法。
-
公开(公告)号:US08895740B2
公开(公告)日:2014-11-25
申请号:US13560122
申请日:2012-07-27
申请人: Juan-Miguel Jimenez , Luca Settimo , Damien Fraysse , Guy Brenchley , Christopher John Davis , Andrew W. Miller
发明人: Juan-Miguel Jimenez , Luca Settimo , Damien Fraysse , Guy Brenchley , Christopher John Davis , Andrew W. Miller
IPC分类号: C07D487/04 , A61K31/4985
CPC分类号: C07D487/04
摘要: The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
摘要翻译: 本发明涉及可用作蛋白激酶抑制剂的化合物。 本发明还提供包含所述化合物的药学上可接受的组合物和使用该组合物治疗各种疾病,病症或病症的方法。 本发明还提供了制备本发明化合物的方法。
-
公开(公告)号:US20140312588A1
公开(公告)日:2014-10-23
申请号:US14365485
申请日:2012-12-13
CPC分类号: B60B30/00 , B60B33/0039 , B60B33/0049 , B60B33/0071 , B60B2200/47 , B60B2900/531 , B60Y2200/126 , B62K3/002
摘要: Scooters typically have a fixed rear wheel and a rotating front wheel on a length forming a handle. Such scooters are not always able to be used to perform tricks and stunts because they have a fixed rear wheel that can inhibit this. In particular many children and adults wish to drift the rear wheel, or have it at oblique angle to the scooter's direction of movement. The present invention provides a scooter wheel mounting capable of forming in use a two wheeled scooter, wherein the rear wheel being provided on a rotatable seat.
摘要翻译: 滑板车通常具有固定的后轮和在形成手柄的长度上的旋转前轮。 这样的踏板车并不总是能够用来执行技巧和特技,因为它们具有可以抑制这种的固定后轮。 特别是许多儿童和成年人希望漂移后轮,或者与滑行车的运动方向倾斜。 本发明提供一种能够在使用中形成二轮摩托车的踏板车轮安装件,其中后轮设置在可旋转的座椅上。
-
-
-
-
-
-
-
-
-